Reaction
Diaphragmatic Disorder reporting signals
As of the last recalculation, Diaphragmatic Disorder appears in 761 FAERS reports alongside 17 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 105.1).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 49 | 105.1 | 105.5 |
| Ipratropium Bromide | 56 | 46.3 | 46.3 |
| Diltiazem Hydrochloride Extended-Release Tablets | 17 | 41.8 | 41.8 |
| Nicotine Polacrilex Mini | 19 | 35.5 | 35.5 |
| Nicotine Polarilex | 19 | 35.5 | 35.5 |
| Pravastatin Sodium | 15 | 21.1 | 21.1 |
| Ezetimibe | 50 | 19.5 | 19.5 |
| Apixaban | 44 | 19.0 | 19.0 |
| Omalizumab | 54 | 18.6 | 18.6 |
| Blinatumomab | 7 | 18.5 | 18.5 |
| Pyrazinamide | 6 | 17.6 | 17.6 |
| Imatinib | 11 | 17.3 | 17.3 |
| Nicotine | 23 | 16.0 | 16.0 |
| Nicotine Polacrilex | 20 | 14.7 | 14.7 |
| Darunavir | 8 | 14.6 | 14.6 |
| Insulin Lispro | 48 | 10.1 | 10.1 |
| Ravulizumab | 4 | 8.1 | 8.1 |